TEL AVIV, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today the appointment of Chris Metzger, M.D., system chair of clinical research at Ballad Health System in […]
Financial
Orient EuroPharma Acquires Equity Stake in Quantum Genomics
PARIS and NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new class of drugs that directly targets the brain to treat difficult-to-treat/resistant hypertension and heart failure, today announced that Orient EuroPharma Co. Ltd (OEP) […]
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
VANCOUVER and MINNEAPOLIS, Feb. 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that it has received written notification from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) pursuant […]
InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
TEL AVIV, Israel, Feb. 08, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (“InspireMD”) (NYSE:NSPR), a medical device company focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East and Asia, today announced the closing […]
Covanos Names Mark D. Carlson, MD as Senior Vice President and Chief Medical Officer
ATLANTA, Feb. 9, 2021 /PRNewswire/ — Covanos, Inc., a privately-held medical technology company that is developing C-HEART, a PC-based software product that uses proprietary advances in computational fluid dynamics to rapidly and non-invasively diagnose the severity of coronary artery blockages, today announced that it has named Mark D. Carlson, MD, MA to the position of […]
Philips completes the acquisition of BioTelemetry, Inc.
Combination of Philips and BioTelemetry results in a global leader in patient care management solutions for the hospital and the home Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has completed the acquisition of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of […]
Silence Therapeutics plc Announces $45 Million Private Placement
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. IN ADDITION, MARKET SOUNDINGS WERE TAKEN IN RESPECT OF THE MATTERS CONTAINED […]
BD Announces First Fiscal Quarter Results; Raises Fiscal 2021 Guidance
– First fiscal quarter revenues of $5.315 billion grew 25.8% on a reported basis. On a currency-neutral basis, revenues increased 24.3%. – BD’s COVID-19 testing sales of $867 million contributed 20.5 percentage points to revenue growth on a reported basis. This includes BD Veritor™ Plus System revenues of $688 million. […]
Windtree Strengthens Its Board by Appointing Three New Directors
Company welcomes Dr. Evan Loh, Ms. Leslie Williams and Dr. Rob Scott, seasoned executives with deep cardiovascular development and commercial experience WARRINGTON, Pa., Feb. 4, 2021 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today […]
Mentice publishes the company’s year-end report for the period January-December 2020
STOCKHOLM, Feb. 4, 2021 /PRNewswire/ — Strong order intake and substantial improvement of the company’s order book as well as operating cash flowFourth quarter (October-December 2020) Order intake amounted to 73.1 (54.7) MSEK. Net sales amounted to 45.9 (60.2) MSEK. Operating income for the period before depreciations (EBITDA) totalled 4.3 (11.8) MSEK. Net […]
Recent
GORE ANNOUNCES FIRST PATIENT ENROLLMENT IN THE GORE® EXCLUDER® IBE PLUS STENT GRAFT PIVOTAL STUDY
XCath Robotics’ Iris System Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP) for Remote Robotic-Assisted Mechanical Thrombectomy in Acute Ischemic Stroke
Riverain Technologies Expands Access to ClearRead™ Advanced Chest Imaging AI Through RapidAI’s Enterprise Platform
Popular
- No commented posts yet